Patent details
EP1480650 Title: NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839
Basic Information
- Publication number:
- EP1480650
- PCT Application Number:
- PCT/GB/2003/000794
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037083193
- PCT Publication Number:
- WO/2003/072108
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NOVEL CRYSTALLINE FORMS OF THE ANTI-CANCER COMPOUND ZD1839
- French Title of Invention:
- FORMES CRISTALLINES DU COMPOSE ANTICANCEREUX ZD1839
- German Title of Invention:
- NEUE KRISTALLINE FORMEN DER KREBSBEKÄMPFENDEN VERBINDUNG ZD1839
- SPC Number:
Dates
- Filing date:
- 24/02/2003
- Grant date:
- 28/04/2010
- EP Publication Date:
- 28/04/2010
- PCT Publication Date:
- 04/09/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/12/2004
- EP B1 Publication Date:
- 28/04/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/02/2011
- Expiration date:
- 24/02/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/02/2003
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- GRAHAM Anthony, Stephen
- Address:
- United Kingdom (GB)
2
- Name:
- GILDAY John, Peter, AstraZeneca Pharmaceuticals
- Address:
- United Kingdom (GB)
3
- Name:
- YMEN Bo, Ingvar
- Address:
- Sweden (SE)
4
- Name:
- BOHLIN Martin
- Address:
- Sweden (SE)
Priority
1
- Priority Number:
- 0204392
- Priority Date:
- 26/02/2002
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0212462
- Priority Date:
- 30/05/2002
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/517;
| Filing date | Document type | Number of pages |
|---|